ATLANTA, April 26, 2012 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its first quarter fiscal year 2012 financial results before the market opens on Friday, May 11, 2012. An investor conference call will follow on the same day at 8:30 a.m. ET.
